[e-drug] ARVs for low income countries: analysis of commercial viability (3)

e-drug
1

E-DRUG: ARVs for low income countries: analysis of commercial viability (3)
---------------------------------------------------------------------------

Dear E-druggers,

This is indeed an interesting article, and not a little disturbing.

Since the cost of APIs as a major component of price is so high:

could not cooperative production of APIs be considered on public health grounds?

If necessary coordinated and supported by UNITAID?

best wishes,

Philippa Saunders
London, UK
Mobile: +44 77 96075366
philippa.m.saunders@gmail.com